Works by Takekuma, Munetaka

Results: 48
    1
    2
    3
    4
    5
    6

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    7
    8

    Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 11, p. 2213, doi. 10.1111/cas.13381
    By:
    • Nishio, Shin;
    • Takekuma, Munetaka;
    • Takeuchi, Satoshi;
    • Kawano, Kouichirou;
    • Tsuda, Naotake;
    • Tasaki, Kazuto;
    • Takahashi, Nobutaka;
    • Abe, Masakazu;
    • Tanaka, Aki;
    • Nagasawa, Takayuki;
    • Shoji, Tadahiro;
    • Xiong, Hao;
    • Nuthalapati, Silpa;
    • Leahy, Terri;
    • Hashiba, Hideyuki;
    • Kiriyama, Tsukasa;
    • Komarnitsky, Philip;
    • Hirashima, Yasuyuki;
    • Ushijima, Kimio
    Publication type:
    Article
    9

    Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.

    Published in:
    2016
    By:
    • Abe, Masakazu;
    • Hirashima, Yasuyuki;
    • Kasamatsu, Yuka;
    • Kado, Nobuhiro;
    • Komeda, Satomi;
    • Kuji, Shiho;
    • Tanaka, Aki;
    • Takahashi, Nobutaka;
    • Takekuma, Munetaka;
    • Hihara, Hanako;
    • Ichikawa, Yoshikazu;
    • Itonaga, Yui;
    • Hirakawa, Tomoko;
    • Nasu, Kaei;
    • Miyagi, Kanoko;
    • Murakami, Junko;
    • Ito, Kimihiko
    Publication type:
    journal article
    10

    The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

    Published in:
    2017
    By:
    • Takekuma, Munetaka;
    • Mori, Keita;
    • Iida, Tetsuji;
    • Kurihara, Kazuko;
    • Saitou, Motoaki;
    • Tokunaga, Hideki;
    • Kawana, Kei;
    • Ikeda, Masae;
    • Satoh, Toyomi;
    • Saito, Toshiaki;
    • Miyagi, Etsuko;
    • Nagai, Yutaka;
    • Furusawa, Akiko;
    • Kawano, Yoshiaki;
    • Kawano, Kouichiro;
    • Tabata, Tsutomu;
    • Ota, Yukinobu;
    • Hayase, Ryoji;
    • Mikami, Mikio;
    • Sugiyama, Toru
    Publication type:
    journal article
    11

    What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 335, doi. 10.1007/s00280-015-2793-9
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Okada, Satoshi;
    • Otsuki, Takeo;
    • Fujiwara, Kiyoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Hasumi, Yoko;
    • Takei, Yuji;
    • Hasegawa, Tetsuya;
    • Matsumoto, Takashi;
    • Fujiwara, Keiichi;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Shimada, Muneaki;
    • Suzuki, Mitsuaki;
    • Kigawa, Junzo
    Publication type:
    Article
    12

    A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 417, doi. 10.1007/s10147-020-01799-3
    By:
    • Kobayashi, Eiji;
    • Kanao, Hiroyuki;
    • Takekuma, Munetaka;
    • Nishio, Shin;
    • Kojima-Chiba, Atsumi;
    • Tozawa, Akiko;
    • Yamaguchi, Satoshi;
    • Takeshima, Nobuhiro;
    • Nakatani, Eiji;
    • Mikami, Mikio
    Publication type:
    Article
    13
    14

    Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2-IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 341, doi. 10.1007/s10147-013-0551-8
    By:
    • Kuji, Shiho;
    • Hirashima, Yasuyuki;
    • Komeda, Satomi;
    • Tanaka, Aki;
    • Abe, Masakazu;
    • Takahashi, Nobutaka;
    • Takekuma, Munetaka;
    • Asakura, Hirofumi;
    • Harada, Hideyuki;
    • Nishimura, Tetsuo
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.

    Published in:
    2020
    By:
    • Takekuma, Munetaka;
    • Takahashi, Fumiaki;
    • Mabuchi, Seiji;
    • Kudaka, Wataru;
    • Horie, Koji;
    • Ikeda, Mariko;
    • Shikama, Ayumi;
    • Mitsuhashi, Akira;
    • Nagao, Shoji;
    • Suzuki, Shiro;
    • Mizuno, Mika;
    • Nishio, Shin;
    • Tokunaga, Hideki;
    • Ota, Yukinobu;
    • Kasamatsu, Takahiro;
    • Kitagawa, Ryo;
    • Toita, Takafumi;
    • Kobayashi, Hiroaki;
    • Ishikawa, Mitsuya;
    • Yaegashi, Nobuo
    Publication type:
    journal article
    21

    Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 674, doi. 10.1007/s10147-025-02716-2
    By:
    • Yokoe, Takamichi;
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    22

    Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 10, p. 1594, doi. 10.1007/s10147-024-02585-1
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Takehara, Kazuhiro;
    • Sato, Shinya;
    • Satoh, Toyomi;
    • Shimada, Muneaki;
    • Yamaguchi, Satoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Horie, Kouji;
    • Takei, Yuji;
    • Imai, Yuichi;
    • Hibino, Yumi;
    • Hasegawa, Kosei;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Takano, Hirokuni;
    • Fujiwara, Keiichi;
    • Masuyama, Hisashi
    Publication type:
    Article
    23

    Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
    By:
    • Hirose, Takeshi;
    • Ito, Mamoru;
    • Tsuchihashi, Kenji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro;
    • Nakao, Shinji
    Publication type:
    Article
    24

    Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
    By:
    • Nozawa, Kazuki;
    • Ozaki, Yukinori;
    • Yoshinami, Tetsuhiro;
    • Yokoe, Takamichi;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    25

    Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
    By:
    • Hirose, Takeshi;
    • Ito, Mamoru;
    • Tsuchihashi, Kenji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro;
    • Nakao, Shinji
    Publication type:
    Article
    26

    Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 899, doi. 10.1007/s10147-023-02461-4
    By:
    • Najima, Yuho;
    • Maeda, Tomoya;
    • Kamiyama, Yutaro;
    • Nakao, Shinji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miumra, Yuji;
    • Endo, Makoto;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita
    Publication type:
    Article
    27

    Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 700, doi. 10.1007/s10147-024-02541-z
    By:
    • Tsuchihashi, Kenji;
    • Ito, Mamoru;
    • Okumura, Yuta;
    • Nio, Kenta;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro
    Publication type:
    Article
    28

    Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 681, doi. 10.1007/s10147-024-02504-4
    By:
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Yokoe, Takamichi;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    29

    Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 689, doi. 10.1007/s10147-024-02502-6
    By:
    • Ito, Mamoru;
    • Okumura, Yuta;
    • Nio, Kenta;
    • Baba, Eishi;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro
    Publication type:
    Article
    30

    Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 559, doi. 10.1007/s10147-024-02501-7
    By:
    • Kimura, Shoji;
    • Shigeta, Keisuke;
    • Tamura, Shingo;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio
    Publication type:
    Article
    31

    Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 551, doi. 10.1007/s10147-024-02499-y
    By:
    • Ozaki, Yukinori;
    • Yokoe, Takamichi;
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    32

    Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 545, doi. 10.1007/s10147-024-02491-6
    By:
    • Uchino, Keita;
    • Tamura, Shingo;
    • Kimura, Shoji;
    • Shigeta, Keisuke;
    • Kimura, Takahiro;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio
    Publication type:
    Article
    33

    Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 535, doi. 10.1007/s10147-023-02465-0
    By:
    • Maeda, Tomoya;
    • Najima, Yuho;
    • Kamiyama, Yutaro;
    • Nakao, Shinji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miumra, Yuji;
    • Endo, Makoto;
    • Maruyama, Dai;
    • Yoshinami, Tatsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita
    Publication type:
    Article
    34

    Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 355, doi. 10.1007/s10147-024-02469-4
    By:
    • Ichihara, Eiki;
    • Ochi, Nobuaki;
    • Makimoto, Go;
    • Kudo, Kenichiro;
    • Harada, Daijiro;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    35

    Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 163, doi. 10.1007/s10147-022-02258-x
    By:
    • Mizuno, Mika;
    • Ito, Kimihiko;
    • Nakai, Hidekatsu;
    • Kato, Hidenori;
    • Kamiura, Shoji;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takano, Hirokuni;
    • Okadome, Masao;
    • Takekuma, Munetaka;
    • Tokunaga, Hideki;
    • Nagase, Satoru;
    • Aoki, Daisuke;
    • Coleman, Robert L.;
    • Nishimura, Yasuko;
    • Ratajczak, Christine K.;
    • Hashiba, Hideyuki;
    • Xiong, Hao;
    • Katsumata, Noriyuki;
    • Enomoto, Takayuki
    Publication type:
    Article
    36

    Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2318, doi. 10.1007/s10147-021-02017-4
    By:
    • Ohta, Tsuyoshi;
    • Nagase, Satoru;
    • Okui, Yosuke;
    • Enomoto, Takayuki;
    • Yamagami, Wataru;
    • Mikami, Mikio;
    • Tokunaga, Hideki;
    • Ino, Kazuhiko;
    • Ushijima, Kimio;
    • Shozu, Makio;
    • Tashiro, Hironori;
    • Mandai, Masaki;
    • Miyamoto, Shingo;
    • Morishige, Ken-Ichirou;
    • Yoshida, Yoshio;
    • Yoshino, Kiyoshi;
    • Saito, Toshiaki;
    • Kobayashi, Eiji;
    • Kobayashi, Hiroaki;
    • Takekuma, Munetaka
    Publication type:
    Article
    37
    38
    39

    Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 12, p. 3676, doi. 10.1245/s10434-018-6695-z
    By:
    • Matsuo, Koji;
    • Takazawa, Yutaka;
    • Ross, Malcolm S.;
    • Elishaev, Esther;
    • Yunokawa, Mayu;
    • Sheridan, Todd B.;
    • Bush, Stephen H.;
    • Klobocista, Merieme M.;
    • Blake, Erin A.;
    • Takano, Tadao;
    • Baba, Tsukasa;
    • Satoh, Shinya;
    • Shida, Masako;
    • Ikeda, Yuji;
    • Adachi, Sosuke;
    • Yokoyama, Takuhei;
    • Takekuma, Munetaka;
    • Yanai, Shiori;
    • Takeuchi, Satoshi;
    • Nishimura, Masato
    Publication type:
    Article
    40

    Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 9, p. 2756, doi. 10.1245/s10434-018-6547-x
    By:
    • Matsuo, Koji;
    • Takazawa, Yutaka;
    • Ross, Malcolm S.;
    • Elishaev, Esther;
    • Yunokawa, Mayu;
    • Sheridan, Todd B.;
    • Bush, Stephen H.;
    • Klobocista, Merieme M.;
    • Blake, Erin A.;
    • Takano, Tadao;
    • Baba, Tsukasa;
    • Satoh, Shinya;
    • Shida, Masako;
    • Ikeda, Yuji;
    • Adachi, Sosuke;
    • Yokoyama, Takuhei;
    • Takekuma, Munetaka;
    • Yanai, Shiori;
    • Takeuchi, Satoshi;
    • Nishimura, Masato
    Publication type:
    Article
    41

    Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.

    Published in:
    Journal of Gynecologic Oncology, 2025, v. 36, n. 3, p. 1, doi. 10.3802/jgo.2025.36.e119
    By:
    • Tohru Morisada;
    • Yoichi Kobayashi;
    • Satoru Nagase;
    • Tsukasa Baba;
    • Hideki Tokunaga;
    • Hidemichi Watari;
    • Munetaka Takekuma;
    • Yasuhisa Terao;
    • Yoshito Terai;
    • Hiroaki Kajiyama;
    • Mikiko Asai-Sato;
    • Kazuhiro Takehara;
    • Tsutomu Tabata;
    • Kenichi Harano;
    • Yasuyuki Hirashima;
    • Mayu Yunokawa;
    • Aikou Okamoto;
    • Mikio Mikami
    Publication type:
    Article
    42
    43

    Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e114
    By:
    • Daisuke Aoki;
    • Tsutomu Tabata;
    • Satoshi Yanagida;
    • Toshiaki Nakamura;
    • Eiji Kondo;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    44
    45

    Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e16
    By:
    • Aikou Okamoto;
    • Eiji Kondo;
    • Toshiaki Nakamura;
    • Satoshi Yanagida;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Tsutomu Tabata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    46

    Clinical utility of CA-125 in the management of uterine carcinosarcoma.

    Published in:
    2018
    By:
    • Koji Matsuo;
    • Ross, Malcolm S.;
    • Mayu Yunokawa;
    • Johnson, Marian S.;
    • Hiroko Machida;
    • Kohei Omatsu;
    • Klobocista, Merieme M.;
    • Im, Dwight D.;
    • Shinya Satoh;
    • Tsukasa Baba;
    • Yuji Ikeda;
    • Bush, Stephen H.;
    • Kosei Hasegawa;
    • Blake, Erin A.;
    • Munetaka Takekuma;
    • Masako Shida;
    • Masato Nishimura;
    • Sosuke Adachi;
    • Tanja Pejovic;
    • Satoshi Takeuchi
    Publication type:
    Letter to the Editor
    47
    48